These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9453427)
1. The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients. McCarthy M; Ramage J; McNair A; Gane E; Portmann B; Pagliuca A; Rela M; Heaton N; Mufti GJ; Williams R J Hepatol; 1997 Dec; 27(6):1015-21. PubMed ID: 9453427 [TBL] [Abstract][Full Text] [Related]
2. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ; Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation. Raymond E; Tricottet V; Samuel D; Reynès M; Bismuth H; Misset JL Cancer; 1995 Oct; 76(8):1344-51. PubMed ID: 8620407 [TBL] [Abstract][Full Text] [Related]
5. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center. Mamzer-Bruneel MF; Lomé C; Morelon E; Levy V; Bourquelot P; Jacobs F; Gessain A; Mac Intyre E; Brousse N; Kreis H; Hermine O J Clin Oncol; 2000 Nov; 18(21):3622-32. PubMed ID: 11054435 [TBL] [Abstract][Full Text] [Related]
7. Post-Transplant Lymphoproliferative Disorder (PTLD) Manifesting in the Oral Cavity of a 13-Year-Old Liver Transplant Recipient (LTx). Krasuska-Sławińska E; Minko-Chojnowska I; Pawłowska J; Dembowska-Bagińska B; Pronicki M; Olczak-Kowalczyk D Ann Transplant; 2015 Aug; 20():478-82. PubMed ID: 26285106 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients. Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073 [TBL] [Abstract][Full Text] [Related]
9. A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. Boulanger E; Agbalika F; Maarek O; Daniel MT; Grollet L; Molina JM; Sigaux F; Oksenhendler E Hematol J; 2001; 2(3):172-9. PubMed ID: 11920242 [TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report. Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782 [TBL] [Abstract][Full Text] [Related]
11. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838 [TBL] [Abstract][Full Text] [Related]
12. [Post-transplantation lymphoproliferative disorder in childhood]. Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients. Strazzabosco M; Corneo B; Iemmolo RM; Menin C; Gerunda G; Bonaldi L; Merenda R; Neri D; Poletti A; Montagna M; Del Mistro A; Faccioli AM; D'Andrea E J Hepatol; 1997 Apr; 26(4):926-34. PubMed ID: 9126809 [TBL] [Abstract][Full Text] [Related]
14. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791 [TBL] [Abstract][Full Text] [Related]